Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimen for Janus Kinase (JAK) inhibitors

Dosing regimen for Janus Kinase (JAK) inhibitors

US Patent 9522151 · Granted Dec 20, 2016

Estimated economic value: $40,459,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies to canine and feline oncostatin M receptor beta and uses thereof2024
IL-31 dog pruritus model2020
Interleukin-31 monoclonal antibody2019
Pyrrolo[2,3-D]pyrimidine derivatives2017
Pyrrolo[2,3-D]pyrimidine derivatives2017
Pyrrolo[2,3-D]pyrimidine compounds2016
Pyrrolo[2,3-d]pyrimidine compounds2015
Pyrrolo[2,3-D]pyrimidine derivatives2015
Pyrrolo[2,3-D]pyrimidine compounds2015
Pyrrolo[2,3-d]pyrimidine compounds2012
Crosslinked DNA condesate compositions and gene delivery methods2004
Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3. 0]-nonan-8-2001